Skip to main content
Erschienen in: Clinical and Experimental Nephrology 5/2011

01.10.2011 | Original Article

Peritonitis is still an important factor for withdrawal from peritoneal dialysis therapy in the Tokai area of Japan

verfasst von: Masashi Mizuno, Yasuhiko Ito, Akio Tanaka, Yasuhiro Suzuki, Hideki Hiramatsu, Midoriko Watanabe, Yoshikazu Tsuruta, Teppei Matsuoka, Isao Ito, Hiroshi Tamai, Hirotake Kasuga, Hideaki Shimizu, Hisashi Kurata, Daijo Inaguma, Takeyuki Hiramatsu, Masanobu Horie, Tomohiko Naruse, Shoichi Maruyama, Enyu Imai, Yukio Yuzawa, Seiichi Matsuo

Erschienen in: Clinical and Experimental Nephrology | Ausgabe 5/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

In Japan, the population of patients on peritoneal dialysis (PD) is <4% of the total number of patients with end-stage renal disease. Few systemic analyses have examined why the number of PD patients has not increased in Japan. We organized a registry to analyze PD patients and retrospectively investigated 561 PD patients (about 5% of all Japanese PD patients) from 13 hospitals in the Tokai area for 3 years from 2005.

Methods

We investigated background, physical status, laboratory data, status of PD therapy, and the occurrence of PD-related complications, and analyzed reasons for withdrawal from PD.

Results

Nutrition did not change significantly during our observation. Urinary volume showed continued decreases after the introduction period. In contrast, PD fluid demand and ultrafiltration volume were significantly increased. For calcium metabolism, multiple phosphate binders were required after the second year of PD therapy. Early drop-out within 3 years after starting PD therapy comprised 50.9% of total withdrawals, with PD-related peritonitis as the most common reason, mainly caused by Gram-positive organisms. Incidence of peritonitis was 42.8 months/patient. Culture-negative results were obtained for 32% of peritonitis cultures. Diabetes affects the prognosis of PD therapy, but not the incidence of peritonitis.

Conclusion

We examined clinical status over 3 years in the Tokai area. The results suggest that the incidence of peritonitis needs to be decreased to prevent early withdrawal of PD patients. Education systems to decrease the incidence of peritonitis and techniques to decrease culture-negative results might be important for improving the prognosis of peritonitis.
Literatur
1.
Zurück zum Zitat Japanese Society for Dialysis Therapy Committee of Renal Data Registry. An overview of regular dialysis treatment in Japan as of Dec 31, 2009; JSDT website: http://www.jsdt.or.jp/. Japanese Society for Dialysis Therapy Committee of Renal Data Registry. An overview of regular dialysis treatment in Japan as of Dec 31, 2009; JSDT website: http://​www.​jsdt.​or.​jp/​.
2.
Zurück zum Zitat Cueto-Manzano AM, Rojas-Campos E. Status of renal replacement therapy and peritoneal dialysis in Mexico. Perit Dial Int. 2007;27:142–8.PubMed Cueto-Manzano AM, Rojas-Campos E. Status of renal replacement therapy and peritoneal dialysis in Mexico. Perit Dial Int. 2007;27:142–8.PubMed
3.
Zurück zum Zitat Yu AW, Chau KF, Ho YW, Li PK. Development of the “peritoneal dialysis first” model in Hong Kong. Perit Dial Int. 2007;27:S53–5.PubMed Yu AW, Chau KF, Ho YW, Li PK. Development of the “peritoneal dialysis first” model in Hong Kong. Perit Dial Int. 2007;27:S53–5.PubMed
4.
Zurück zum Zitat Kawaguchi Y, Ishizaki T, Imada A, Oohira S, Kuriyama S, Nakamoto H, et al. Searching for the reasons for drop-out from peritoneal dialysis: a nationwide survey in Japan. Perit Dial Int. 2003;23:S175–7.PubMed Kawaguchi Y, Ishizaki T, Imada A, Oohira S, Kuriyama S, Nakamoto H, et al. Searching for the reasons for drop-out from peritoneal dialysis: a nationwide survey in Japan. Perit Dial Int. 2003;23:S175–7.PubMed
5.
Zurück zum Zitat Kawaguchi Y. Various obstacles to peritoneal dialysis development in Japan: too much money? Too much fear? Perit Dial Int. 2007;27:S56–8.PubMed Kawaguchi Y. Various obstacles to peritoneal dialysis development in Japan: too much money? Too much fear? Perit Dial Int. 2007;27:S56–8.PubMed
6.
Zurück zum Zitat Nakamoto H, Kawaguchi Y, Suzuki H. Is technique survival on peritoneal dialysis better in Japan? Perit Dial Int. 2006;26:136–43.PubMed Nakamoto H, Kawaguchi Y, Suzuki H. Is technique survival on peritoneal dialysis better in Japan? Perit Dial Int. 2006;26:136–43.PubMed
7.
Zurück zum Zitat Masakane I, Tsubakihara Y, Akiba T, Watanabe Y, Iseki K. The most recent trends of peritoneal dialysis in Japan. Perit Dial Int. 2008;28:S27–31.PubMed Masakane I, Tsubakihara Y, Akiba T, Watanabe Y, Iseki K. The most recent trends of peritoneal dialysis in Japan. Perit Dial Int. 2008;28:S27–31.PubMed
8.
Zurück zum Zitat Moncrief JW, Popovich RP, Broadrick LJ, He ZZ, Simmons EE, Tate RA. The Moncrief-Popovich catheter. A new peritoneal access technique for patients on peritoneal dialysis. ASAIO J. 1993;39:62–5.CrossRefPubMed Moncrief JW, Popovich RP, Broadrick LJ, He ZZ, Simmons EE, Tate RA. The Moncrief-Popovich catheter. A new peritoneal access technique for patients on peritoneal dialysis. ASAIO J. 1993;39:62–5.CrossRefPubMed
9.
Zurück zum Zitat Piraino B, Bailie GR, Bernardini J, Boeschoten E, Gupta A, Holmes C, et al. Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int. 2005;25:107–31.PubMed Piraino B, Bailie GR, Bernardini J, Boeschoten E, Gupta A, Holmes C, et al. Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int. 2005;25:107–31.PubMed
10.
Zurück zum Zitat Li PK, Szeto CC, Piraino B, Bernardini J, Figueiredo AE, Gupta A, et al. ISPD guidelines/recommendation. Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int. 2010;30:393–423.CrossRefPubMed Li PK, Szeto CC, Piraino B, Bernardini J, Figueiredo AE, Gupta A, et al. ISPD guidelines/recommendation. Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int. 2010;30:393–423.CrossRefPubMed
11.
Zurück zum Zitat Okada S, Inoue T, Nakamoto H, Ikeda N, Sugahara S, Shoda J, et al. Residual renal function plays an important role in regulating parathyroid hormone in patients on continuous ambulatory peritoneal dialysis. Adv Perit Dial. 2007;23:150–4.PubMed Okada S, Inoue T, Nakamoto H, Ikeda N, Sugahara S, Shoda J, et al. Residual renal function plays an important role in regulating parathyroid hormone in patients on continuous ambulatory peritoneal dialysis. Adv Perit Dial. 2007;23:150–4.PubMed
12.
Zurück zum Zitat Kawanishi H, Kawaguchi Y, Fukui H, Hara S, Imada A, Kubo H, et al. Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study. Am J Kidney Dis. 2004;44:729–37.CrossRefPubMed Kawanishi H, Kawaguchi Y, Fukui H, Hara S, Imada A, Kubo H, et al. Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study. Am J Kidney Dis. 2004;44:729–37.CrossRefPubMed
13.
Zurück zum Zitat Chung SH, Heimbürger O, Lindholm B, Lee HB. Peritoneal dialysis patient survival: a comparison between a Swedish and a Korean centre. Nephrol Dial Transplant. 2005;20:1207–13.CrossRefPubMed Chung SH, Heimbürger O, Lindholm B, Lee HB. Peritoneal dialysis patient survival: a comparison between a Swedish and a Korean centre. Nephrol Dial Transplant. 2005;20:1207–13.CrossRefPubMed
14.
Zurück zum Zitat Mactier R. Peritonitis is still the achilles’ heel of peritoneal dialysis. Perit Dial Int. 2009;29:262–6.PubMed Mactier R. Peritonitis is still the achilles’ heel of peritoneal dialysis. Perit Dial Int. 2009;29:262–6.PubMed
15.
Zurück zum Zitat Abraham G, Pratap B, Sankarasubbaiyan S, Govindan P, Nayak KS, Sheriff R, et al. Chronic peritoneal dialysis in South Asia—challenges and future. Perit Dial Int. 2008;28:13–9.PubMed Abraham G, Pratap B, Sankarasubbaiyan S, Govindan P, Nayak KS, Sheriff R, et al. Chronic peritoneal dialysis in South Asia—challenges and future. Perit Dial Int. 2008;28:13–9.PubMed
16.
Zurück zum Zitat Davenport A. Peritonitis remains the major clinical complication of peritoneal dialysis: the London, UK, peritonitis audit 2002–2003. Perit Dial Int. 2009;29:297–302.PubMed Davenport A. Peritonitis remains the major clinical complication of peritoneal dialysis: the London, UK, peritonitis audit 2002–2003. Perit Dial Int. 2009;29:297–302.PubMed
17.
Zurück zum Zitat Bernardini J, Price V, Figueiredo A, Riemann A, Leung D. International survey of peritoneal dialysis training program. Perit Dial Int. 2006;26:658–63.PubMed Bernardini J, Price V, Figueiredo A, Riemann A, Leung D. International survey of peritoneal dialysis training program. Perit Dial Int. 2006;26:658–63.PubMed
18.
Zurück zum Zitat Huisman RM, Nieuwenhuizen MG, Th de Charro F. Patient-related and centre-related factors influencing technique survival of peritoneal dialysis in The Netherlands. Nephrol Dial Transplant. 2002;17:1655–60.CrossRefPubMed Huisman RM, Nieuwenhuizen MG, Th de Charro F. Patient-related and centre-related factors influencing technique survival of peritoneal dialysis in The Netherlands. Nephrol Dial Transplant. 2002;17:1655–60.CrossRefPubMed
19.
Zurück zum Zitat Plantinga LC, Fink NE, Finkelstein FO, Powe NR, Jaar BG. Association of peritoneal dialysis clinic size with clinical outcomes. Perit Dial Int. 2009;29:285–91.PubMedPubMedCentral Plantinga LC, Fink NE, Finkelstein FO, Powe NR, Jaar BG. Association of peritoneal dialysis clinic size with clinical outcomes. Perit Dial Int. 2009;29:285–91.PubMedPubMedCentral
20.
Zurück zum Zitat Han SH, Lee SC, Ahn SV, Lee JE, Choi HY, Kim BS, et al. Improving outcome of CAPD: twenty-five years’ experience in a single Korean center. Perit Dial Int. 2007;27:432–40.PubMed Han SH, Lee SC, Ahn SV, Lee JE, Choi HY, Kim BS, et al. Improving outcome of CAPD: twenty-five years’ experience in a single Korean center. Perit Dial Int. 2007;27:432–40.PubMed
21.
Zurück zum Zitat Russo R, Manili L, Tiraboschi G, Amar K, De Luca M, Alberghini E, et al. Patient re-training in peritoneal dialysis: why and when it is needed. Kidney Int. 2006;103:S127–32.CrossRef Russo R, Manili L, Tiraboschi G, Amar K, De Luca M, Alberghini E, et al. Patient re-training in peritoneal dialysis: why and when it is needed. Kidney Int. 2006;103:S127–32.CrossRef
22.
Zurück zum Zitat Chow KM, Szeto CC, Leung CB, Law MC, Kawan BC, Li PK. Adherence to peritoneal dialysis training schedule. Nephrol Dial Transplant. 2007;22:545–51.CrossRefPubMed Chow KM, Szeto CC, Leung CB, Law MC, Kawan BC, Li PK. Adherence to peritoneal dialysis training schedule. Nephrol Dial Transplant. 2007;22:545–51.CrossRefPubMed
23.
Zurück zum Zitat Kuriyama S. Peritoneal dialysis in patients with diabetes: are the benefits greater than the disadvantages? Perit Dial Int. 2007;27:S190–5.PubMed Kuriyama S. Peritoneal dialysis in patients with diabetes: are the benefits greater than the disadvantages? Perit Dial Int. 2007;27:S190–5.PubMed
24.
Zurück zum Zitat Paniagua R, Orihuela O, Ventura MD, Avila-Díaz M, Cisneros A, Vicenté-Martínez M, et al. Echocardiographic, electrocardiographic and blood pressure changes induced by icodextrin solution in diabetic patients on peritoneal dialysis. Kidney Int. 2008;108:S125–30.CrossRef Paniagua R, Orihuela O, Ventura MD, Avila-Díaz M, Cisneros A, Vicenté-Martínez M, et al. Echocardiographic, electrocardiographic and blood pressure changes induced by icodextrin solution in diabetic patients on peritoneal dialysis. Kidney Int. 2008;108:S125–30.CrossRef
25.
Zurück zum Zitat Ramo’n P, Ventura M, A’vila-Díaz M, Cisneros A, Vicenté-Martínez M, Furlong M, et al. Icodextrin improves metabolic and fluid management in high and high-average transport diabetic patients. Perit Dial Int. 2009;29:422–32. Ramo’n P, Ventura M, A’vila-Díaz M, Cisneros A, Vicenté-Martínez M, Furlong M, et al. Icodextrin improves metabolic and fluid management in high and high-average transport diabetic patients. Perit Dial Int. 2009;29:422–32.
26.
Zurück zum Zitat Lin A, Qian J, Li X, Yu X, Liu W, Sun Y, et al. Randomized controlled trial of icodextrin versus glucose containing peritoneal dialysis fluid. Clin J Am Soc Nephrol. 2009;4:1799–804.CrossRefPubMedPubMedCentral Lin A, Qian J, Li X, Yu X, Liu W, Sun Y, et al. Randomized controlled trial of icodextrin versus glucose containing peritoneal dialysis fluid. Clin J Am Soc Nephrol. 2009;4:1799–804.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Martinez-Mier G, Garcia-Almazan E, Reyes-Devesa HE, Garcia-Garcia V, Cano-Gutierrez S, Mora y Fermin R, et al. Abdominal wall hernia in end-stage renal disease patients on peritoneal dialysis. Perit Dial Int. 2008;28:391–6.PubMed Martinez-Mier G, Garcia-Almazan E, Reyes-Devesa HE, Garcia-Garcia V, Cano-Gutierrez S, Mora y Fermin R, et al. Abdominal wall hernia in end-stage renal disease patients on peritoneal dialysis. Perit Dial Int. 2008;28:391–6.PubMed
28.
Zurück zum Zitat Twardowski ZJ. PET—a simpler approach for determining prescriptions for adequate dialysis therapy. Adv Perit Dial. 1990;6:186–91.PubMed Twardowski ZJ. PET—a simpler approach for determining prescriptions for adequate dialysis therapy. Adv Perit Dial. 1990;6:186–91.PubMed
Metadaten
Titel
Peritonitis is still an important factor for withdrawal from peritoneal dialysis therapy in the Tokai area of Japan
verfasst von
Masashi Mizuno
Yasuhiko Ito
Akio Tanaka
Yasuhiro Suzuki
Hideki Hiramatsu
Midoriko Watanabe
Yoshikazu Tsuruta
Teppei Matsuoka
Isao Ito
Hiroshi Tamai
Hirotake Kasuga
Hideaki Shimizu
Hisashi Kurata
Daijo Inaguma
Takeyuki Hiramatsu
Masanobu Horie
Tomohiko Naruse
Shoichi Maruyama
Enyu Imai
Yukio Yuzawa
Seiichi Matsuo
Publikationsdatum
01.10.2011
Verlag
Springer Japan
Erschienen in
Clinical and Experimental Nephrology / Ausgabe 5/2011
Print ISSN: 1342-1751
Elektronische ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-011-0471-8

Weitere Artikel der Ausgabe 5/2011

Clinical and Experimental Nephrology 5/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.